These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 2943774

  • 1. The dexamethasone suppression test, the Hamilton Depression Rating Scale and the DSM-III depression categories.
    Maes M, De Ruyter M, Hobin P, Suy E.
    J Affect Disord; 1986; 10(3):207-14. PubMed ID: 2943774
    [Abstract] [Full Text] [Related]

  • 2. Use of the dexamethasone suppression test in an inpatient setting: a replication and new findings.
    Maes M, De Ruyter M, Suy E.
    Psychoneuroendocrinology; 1989; 14(3):231-9. PubMed ID: 2756075
    [Abstract] [Full Text] [Related]

  • 3. Prediction of subtype and severity of depression by means of dexamethasone suppression test, L-tryptophan: competing amino acid ratio, and MHPG flow.
    Maes MH, De Ruyter M, Suy E.
    Biol Psychiatry; 1987 Feb; 22(2):177-88. PubMed ID: 3814668
    [Abstract] [Full Text] [Related]

  • 4. Results of the 8 a.m. dexamethasone suppression test constitute a suitable tool for confirming the diagnosis of melancholia. A test unaffected by the variations in the bioavailability of dexamethasone.
    Maes M, Vandewoude M, Schotte C, Cosyns P.
    Neuropsychobiology; 1989 Feb; 22(1):26-32. PubMed ID: 2639285
    [Abstract] [Full Text] [Related]

  • 5. The influences of dexamethasone levels on the predictive value of the DST for unipolar major depression and the relationships between post-dexamethasone cortisol and ACTH levels.
    Maes M, Minner B, Suy E.
    J Affect Disord; 1989 Feb; 17(1):39-46. PubMed ID: 2544636
    [Abstract] [Full Text] [Related]

  • 6. The diagnostic performance of the L-tryptophan/competing amino acids ratio in major depression.
    Maes M, De Ruyter M, Hobin P, Suy E.
    Acta Psychiatr Belg; 1986 Feb; 86(3):257-65. PubMed ID: 3751649
    [Abstract] [Full Text] [Related]

  • 7. An augmented escape of beta-endorphins to suppression by dexamethasone in severely depressed patients.
    Maes M, Jacobs MP, Suy E, Leclercq C, Christiaens F, Raus J.
    J Affect Disord; 1990 Mar; 18(3):149-56. PubMed ID: 2139059
    [Abstract] [Full Text] [Related]

  • 8. The clinical use of the dexamethasone suppression test in DSM-III affective disorders: correlation with the severe depressive subtypes of melancholia and psychosis.
    Evans DL, Nemeroff CB.
    J Psychiatr Res; 1987 Mar; 21(2):185-94. PubMed ID: 3585807
    [Abstract] [Full Text] [Related]

  • 9. Dexamethasone suppression test (DST) and plasma dexamethasone levels in depressed patients.
    Johnson GF, Hunt G, Kerr K, Caterson I.
    Psychiatry Res; 1984 Dec; 13(4):305-13. PubMed ID: 6596587
    [Abstract] [Full Text] [Related]

  • 10. Serum postdexamethasone prolactin measures in depressive patients and control subjects.
    Maes M, Schotte C, Peeters D, D'Hondt P, Martin M, Blockx P, Minner B, Suy E, Cosyns P.
    J Psychiatr Res; 1991 Dec; 25(3):109-16. PubMed ID: 1941707
    [Abstract] [Full Text] [Related]

  • 11. The cortisol suppression index and the dexamethasone suppression test in major depression.
    Maes M, De Ruyter M, Suy E.
    Acta Psychiatr Belg; 1987 Dec; 87():633-9. PubMed ID: 3452982
    [Abstract] [Full Text] [Related]

  • 12. Abnormal pituitary function during melancholia: reduced alpha-melanocyte-stimulating hormone secretion and increased intact ACTH non-suppression.
    Maes M, DeJonckheere C, Vandervorst C, Schotte C, Cosyns P, Raus J, Suy E.
    J Affect Disord; 1991 Jul; 22(3):149-57. PubMed ID: 1655852
    [Abstract] [Full Text] [Related]

  • 13. Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions.
    Stewart JW, Quitkin FM, McGrath PJ, Klein DF.
    J Affect Disord; 2005 Jun; 86(2-3):161-7. PubMed ID: 15935235
    [Abstract] [Full Text] [Related]

  • 14. The DST and its relationship to psychiatric diagnosis, symptoms and treatment outcome.
    Klein HE, Bender W, Mayr H, Niederschweiberer A, Schmauss M.
    Br J Psychiatry; 1984 Dec; 145():591-9. PubMed ID: 6509268
    [Abstract] [Full Text] [Related]

  • 15. Dexamethasone suppression test in a pluridiagnostic approach: its relationship to psychopathological and clinical variables.
    Kasper S, Beckmann H.
    Acta Psychiatr Scand; 1983 Jul; 68(1):31-7. PubMed ID: 6613617
    [Abstract] [Full Text] [Related]

  • 16. The dexamethasone suppression test in adolescent outpatients with major depressive disorder.
    Birmaher B, Dahl RE, Ryan ND, Rabinovich H, Ambrosini P, al-Shabbout M, Novacenko H, Nelson B, Puig-Antich J.
    Am J Psychiatry; 1992 Aug; 149(8):1040-5. PubMed ID: 1636803
    [Abstract] [Full Text] [Related]

  • 17. Computerized brain tomography measures compared with spontaneous and suppressed plasma cortisol levels in major depression.
    Schlegel S, von Bardeleben U, Wiedemann K, Frommberger U, Holsboer F.
    Psychoneuroendocrinology; 1989 Aug; 14(3):209-16. PubMed ID: 2756074
    [Abstract] [Full Text] [Related]

  • 18. Afternoon cortisol levels before (spontaneous) and after suppression with dexamethasone or oxazepam in depressed patients.
    Christensen P, Gram LF, Kragh-Sørensen P, Nielsen S.
    J Affect Disord; 1986 Aug; 10(3):171-6. PubMed ID: 2943769
    [Abstract] [Full Text] [Related]

  • 19. The dexamethasone suppression test in adolescent psychiatric inpatients.
    Targum SD, Capodanno AE.
    Am J Psychiatry; 1983 May; 140(5):589-91. PubMed ID: 6846588
    [Abstract] [Full Text] [Related]

  • 20. The dexamethasone suppression test: identification of subtypes of depression.
    Schatzberg AF, Rothschild AJ, Stahl JB, Bond TC, Rosenbaum AH, Lofgren SB, MacLaughlin RA, Sullivan MA, Cole JO.
    Am J Psychiatry; 1983 Jan; 140(1):88-91. PubMed ID: 6847992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.